35.44 ng/mL, IQR 28.61–46.34 ng/mL; p = 0.002), whereas the exacerbation subgroup showed a trend toward increased levels (Figure 3A ).
← all excerpts
sFGL2 as a Potential Immunosuppressive Biomarker Associated With COVID-19 Severity in Kidney Transplant Recipients.
1
—
—